For example, CYP2C9 and CYP2C19 variants (in particular CYP2C9 poor metabolizer genotypes), are associated with phenytoin-induced SJS/TEN even in the absence of HLA-B*1502 [46, 47]
We care about the success of our patients, and we strive to provide them with the perfect treatment plan for their needs and goals
A study of postmenopausal women with overweight or obesity, published in the Lancet Obstetrics, Gynaecology, & Womens Health in early 2026, found that women taking tirzepatide plus hormone replacement therapy lost more weight than women taking tirzepatide alone
Drug safety update: GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued
Most of these side effects are not serious, but they can be uncomfortable
So, it is a good choice for patients who want to work towards long-time weight loss goals